Search Within

Beatrice Fregonese

Formats
  1. Meeting Abstract (46)
  2. Journal Article (4)
Groups
  1. Radiation Oncology, Department of (50)
  2. Survivorship Research (50)
  3. Graduate Medical Education (45)
  4. GME, Radiation Oncology (44)
  5. Department of Medicine (26)
  6. Hematologic Malignancies, Division of (26)

More Groups

People
  1. Joachim Yahalom (50)
  2. Brandon Imber (49)
  3. Carla Hajj (37)
  4. Harper Hubbeling (22)
  5. Jisun Lee (21)
  6. Alexandra Dreyfuss (19)

More People

Years
  1. 2025 (2)
  2. 2024 (18)
  3. 2023 (23)
  4. 2022 (6)
  5. 2021 (1)
Publications
  1. Blood (16)
  2. International Journal of Radiation Oncology, Biology, Physics (14)
  3. Hematological Oncology (11)
  4. Blood Advances (2)
  5. Neuro-Oncology (2)
  6. Radiotherapy and Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (18)
  2. Elsevier Inc. (16)
  3. Wiley Blackwell (11)
  4. Oxford University Press (2)
  5. American Association for Cancer Research (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (50)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic alterations in follicular lymphoma predict response to very low dose radiotherapy
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E.; Chan, A.; Lee, J.; Fregonese, B.; Hajj, C.; Cedarquist, G.; Hubbeling, H.; Ma, J.; Sarkar, R.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Very low dose radiation therapy for indolent lymphoma: Comparing "Big Boom" (4GY × 1) versus "Boom Boom" (2GY × 2)
    Meeting Abstract

    Hajj, C.; Lee, J.; Boe, L.; Fregonese, B.; Lebow, E.; Wijetunga, N. A.; Hubbeling, H.; Tringale, K.; Freret, M.; Imber, B.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T‐cell therapy outcome
    Meeting Abstract

    Imber, B. S.; Silverman, E. A.; Leithner, D.; Hubbeling, H.; Shah, G. L.; Fregonese, B.; Sanin, B. W.; Tomas, A. A.; Parascondola, A.; Saldia, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Predictors of response to radiation therapy and of progression to multiple myeloma in patients with solitary bone and extramedullary plasmacytomas
    Meeting Abstract

    Fregonese, B.; Dreyfuss, A.; Lee, J.; Imber, B. S.; Yahalom, J.; Hajj, C.
    Blood (2022)

    Fulltext@MSK | Save
  • Radiotherapy for secondary CNS lymphoma: Patterns of utilization and clinical outcomes
    Meeting Abstract

    Cederquist, G. Y.; Tringale, K. R.; Hajj, C.; Hubbeling, H.; Fregonese, B.; Lee, J.; Scordo, M.; Grommes, C.; Yahalom, J.; Imber, B. S.
    Blood (2022)

    Fulltext@MSK | Save
  • Genetic Alterations of CREBBP are associated with radiosensitivity in follicular lymphoma
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E. S.; Lee, J.; Fregonese, B.; Tringale, K. R.; Hubbeling, H.; Sarkar, R.; Ma, J.; Seshan, V.; Joffe, E.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • "Big Boom" (4 Gy x 1) radiation treatment (RT) versus "Big Boom" (2 Gy x 2) for non-Hodgkin lymphoma (NHL)
    Meeting Abstract

    Hajj, C.; Lebow, E. S.; Lee, J.; Fregonese, B.; Wijetunga, N. A.; Hubbeling, H.; Tringale, K. R.; Freret, M. E.; Imber, B. S.; Yahalom, J.
    Blood (2022)

    Fulltext@MSK | Save
  • Predictors of response to radiation therapy and of progression to multiple myeloma in patients with solitary bone and solitary extramedullary plasmacytomas
    Meeting Abstract

    Fregonese, B.; Imber, B. S.; Lee, J.; Yahalom, J.; Hajj, C.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • The role of radiation therapy in the treatment of primary hepatic lymphomas
    Meeting Abstract

    Ma, J.; Daou, R.; Eid, J. B.; Lee, J.; Fregonese, B.; El-Khoury, J.; Wijetunga, N. A.; Hubbeling, H.; Tringale, K.; Lebow, E.; more...
    Radiotherapy and Oncology (2022)

    Fulltext@MSK | Save
  • "Big Boom" radiation treatment (RT) of 4 Gy single fraction: Is it an acceptable alternative to "Boom Boom" radiation treatment 2 Gyx2 fractions for non-Hodgkin lymphomas (NHL)?
    Meeting Abstract

    Hajj, C.; Lee, J.; Fregonese, B.; Imber, B. S.; Wijetunga, N. A.; Yang, J. C.; Casey, D. L.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save